UK's MHRA: Novo’s Semaglutide Injection Approved To Treat Metabolic-Associated Steatohepatitis In Adults With Moderate-to-Advanced Liver Fib

UK's MHRA: Novo’s Semaglutide Injection Approved To Treat Metabolic-Associated Steatohepatitis In Adults With Moderate-to-Advanced Liver Fibrosis